Santarpia L - Search Results

1

Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.

Győrffy B, Bottai G, Fleischer T, Munkácsy G, Budczies J, Paladini L, Børresen-Dale AL, Kristensen VN, Santarpia L. Győrffy B, et al. Among authors: santarpia l. Int J Cancer. 2016 Jan 1;138(1):87-97. doi: 10.1002/ijc.29684. Epub 2015 Jul 30. Int J Cancer. 2016. PMID: 26174627 Free article. Review.

2

A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.

Kleivi Sahlberg K, Bottai G, Naume B, Burwinkel B, Calin GA, Børresen-Dale AL, Santarpia L. Kleivi Sahlberg K, et al. Among authors: santarpia l. Clin Cancer Res. 2015 Mar 1;21(5):1207-14. doi: 10.1158/1078-0432.CCR-14-2011. Epub 2014 Dec 29. Clin Cancer Res. 2015. PMID: 25547678

3

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.

Lánczky A, Nagy Á, Bottai G, Munkácsy G, Szabó A, Santarpia L, Győrffy B. Lánczky A, et al. Among authors: santarpia l. Breast Cancer Res Treat. 2016 Dec;160(3):439-446. doi: 10.1007/s10549-016-4013-7. Epub 2016 Oct 15. Breast Cancer Res Treat. 2016. PMID: 27744485

4

Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer.

Bottai G, Diao L, Baggerly KA, Paladini L, Győrffy B, Raschioni C, Pusztai L, Calin GA, Santarpia L. Bottai G, et al. Among authors: santarpia l. Int J Mol Sci. 2017 Jan 19;18(1):194. doi: 10.3390/ijms18010194. Int J Mol Sci. 2017. PMID: 28106823 Free PMC article.

5

An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes.

Győrffy B, Pongor L, Bottai G, Li X, Budczies J, Szabó A, Hatzis C, Pusztai L, Santarpia L. Győrffy B, et al. Among authors: santarpia l. Br J Cancer. 2018 Apr;118(8):1107-1114. doi: 10.1038/s41416-018-0030-0. Epub 2018 Mar 21. Br J Cancer. 2018. PMID: 29559730 Free PMC article.

6

Targeting the microRNA-regulating DNA damage/repair pathways in cancer.

Bottai G, Pasculli B, Calin GA, Santarpia L. Bottai G, et al. Among authors: santarpia l. Expert Opin Biol Ther. 2014 Nov;14(11):1667-83. doi: 10.1517/14712598.2014.950650. Epub 2014 Sep 5. Expert Opin Biol Ther. 2014. PMID: 25190496 Review.

7

A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer.

Menyhárt O, Santarpia L, Győrffy B. Menyhárt O, et al. Among authors: santarpia l. Curr Cancer Drug Targets. 2015;15(8):665-83. doi: 10.2174/156800961508151001101742. Curr Cancer Drug Targets. 2015. PMID: 26452383 Review.

8

miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.

Adams BD, Wali VB, Cheng CJ, Inukai S, Booth CJ, Agarwal S, Rimm DL, Győrffy B, Santarpia L, Pusztai L, Saltzman WM, Slack FJ. Adams BD, et al. Among authors: santarpia l. Cancer Res. 2016 Feb 15;76(4):927-39. doi: 10.1158/0008-5472.CAN-15-2321. Epub 2015 Dec 16. Cancer Res. 2016. PMID: 26676753 Free PMC article.

9

Targeting microRNAs as key modulators of tumor immune response.

Paladini L, Fabris L, Bottai G, Raschioni C, Calin GA, Santarpia L. Paladini L, et al. Among authors: santarpia l. J Exp Clin Cancer Res. 2016 Jun 27;35:103. doi: 10.1186/s13046-016-0375-2. J Exp Clin Cancer Res. 2016. PMID: 27349385 Free PMC article. Review.

10

Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer.

Santarpia L, Bottai G, Kelly CM, Győrffy B, Székely B, Pusztai L. Santarpia L, et al. Oncologist. 2016 Sep;21(9):1063-78. doi: 10.1634/theoncologist.2015-0369. Epub 2016 Jul 6. Oncologist. 2016. PMID: 27384237 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page